Clinical Trial Update: Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating tacrolimus and mycophenolate mofetil as post-grafting immunosuppression after conditioning with Flu TBI in HLA-matched related…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndrome

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Colorado Blood Cancer Institute | Conditions: Multiple Myeloma, Lymphoma | Phase 2 | Status: UNKNOWN